viernes, 24 de febrero de 2017

Register your study with ISRCTN today!

BioMed Central – The Open Access Publisher

Register your study with ISRCTN today!

Registration of clinical trials and other studies is the first step towards transparency and the future dissemination of research outcomes.
An increasing number of journals, including Journal of Hematology & OncologyMolecular Cancer and BMC Cancer, require registration before publication of the protocol and/or the results.
The ISRCTN registry administered by BioMed Central accepts all study designs involving human subjects.
Why not register your study with us today?

The ISRCTN registry, administered by BioMed Central, accepts all study designs involving human subjects, whether interventional or observational, proposed or completed or ongoing.

Featured related blog post
World Cancer Day is an international event that aims to unite the world against cancer. Here at the ISRCTN registry, we are showing our support by exploring some of the research we have registered in this field.

Why register with ISRCTN?
Comply with international regulations – Primary clinical trial registry recognised by WHO and ICMJE
Benefit from editorial help – Content is reviewed and curated by a team of expert editors
Register at any time – Prospective and retrospective registrations accepted
Access over 15,000 records – Freely accessible and searchable database
Keep information up to date – Records are regularly reviewed and updated
Bring research to a wider audience – Over 4,000 records have a plain English summary

Best wishes,

Don’t forget to follow @ISRCTN on Twitter, and you can always email us at with any enquiries you may have.

For further information or enquiries please contact Customer Services
BioMed Central Ltd 
236 Gray's Inn Road, London, WC1X 8HB, 
United Kingdom.

No hay comentarios:

Publicar un comentario